Clinical Trial: Acceptance and Commitment Therapy for Chemsex

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980974) titled 'Acceptance and Commitment Therapy for Chemsex' on April 21.

Brief Summary: Quasi-randomized control trial of acceptance and commitment therapy (ACT) for chemsex.

Study Start Date: Dec. 01, 2025

Study Type: INTERVENTIONAL

Condition: Chemsex

Intervention: BEHAVIORAL: ACT-for-chemsex

16 weeks of acceptance and commitment therapy, delivered online weekly, 45-55 minute sessions

OTHER: Treatment as Usual (TAU)

Participants in TAU will receive health/mental health interventions as needed

Recruitment Status: NOT_YET_RECRUITING

Sponsor: University of Alabama at Birmingham

Information provided by (Responsible Party): Nicholas C. Bo...